Alpha Tau Medical Ltd. Warrant

Alpha Tau Medical Ltd. Warrant is a financial derivative that grants the holder the right, but not the obligation, to purchase shares of Alpha Tau Medical Ltd. at a predetermined price before or at the expiration date. Warrants such as these are often issued by companies as a means to raise capital or as part of a larger financing deal. This particular warrant is tied to Alpha Tau Medical Ltd., a company involved in the development and commercialization of Alpha DaRT, a novel alpha radiation cancer therapy. The use of warrants can provide investors with a leveraged exposure to the underlying shares, appealing to those looking to enhance their investment strategies. In the financial markets, warrants are distinct from options in terms of their issuance, duration, and trading processes, and they play a crucial role for companies aiming to incentivize investors to engage in long-term growth plans.